Edit
Elevation
http://www.elevationpharma.com/Last activity: 04.01.2012
Active - Reference to Sunovion Pharmaceuticals
ELEVATION PHARMACEUTICALS (acquired by Sunovion Pharmaceuticals in 2012 through a merger) develops improved aerosol therapies for patients who require nebulizer delivery of their medicines.
Location: United States, Massachusetts, Marlborough
Employees: 11-50
Total raised: $47M
Investors 1
Funding Rounds 2
| Date | Series | Amount | Investors |
| 04.01.2012 | Series B | $30M | - |
| 28.09.2011 | Series A | $17M | - |
Mentions in press and media 8
| Date | Title | Description |
| 04.01.2012 | Novo Leads New $30M Round for San Diego’s Elevation Pharmaceuticals | Share Share on Facebook Share on Twitter LinkedIn Email Reprints San Diego’s Elevation Pharmaceuticals says today it’s raised $30 million in Series B funding, which is expected to carry the startup through its mid-stage trials for a new aer... |
| 04.01.2012 | Elevation Pharmaceuticals Raises $30M | San Diego-based Elevation Pharmaceuticals, which is developing treatment for patients with chronic obstructive pulmonary disease (COPD), said this morning that it has closed on a $30M, Series B funding round. The round was led by Novo Ventu... |
| 04.01.2012 | Elevation Pharmaceuticals Closes $30M Series B Financing | Elevation Pharmaceuticals, Inc., a San Diego, California-based biopharmaceutical company developing new inhaled therapies for patients with respiratory disease, has closed a $30m Series B financing. The round was led by new investor Novo Ve... |
| 04.01.2012 | Elevation Pharmaceuticals Seals $30M Series B | SAN DIEGO, CA, Round led by new investor Novo Ventures will fund development of Elevation's new aerosol therapy for patients living with chronic obstructive pulmonary disease. >> Click here for more funding data on Elevation Pharma... |
| 28.09.2011 | Elevation Pharmaceuticals Raises $17m Second Tranche of Series A Financing | Elevation Pharmaceuticals, a San Diego, CA-based biopharmaceutical company focused on the development of new aerosol therapies for patients with respiratory diseases, has drawn down a $17m second tranche of its Series A financing. Backers i... |
| 26.09.2011 | Elevation Pharmaceuticals Pulls In $17M, Names Execs | San Diego-based Elevation Pharmaceuticals announced today that it has drawn down a $17M, tranched Series A financing for the company, and also appointed a number of executives. The company also said it has named Jaisim Shah as Senior Vice P... |
| 22.01.2010 | Elevation Pharmaceuticals Raises $30M | San Diego-based startup Elevation Pharmaceuticals Inc... Take 1 minute to subscribe and you'll get this story immediately, plus: Already a subscriber? Sign in 52 weekly issues Subscriber-only digital content every business day, plus full ac... |
| 21.01.2010 | Elevation Pharmaceuticals Raises $30M in Series A Financing | Elevation Pharmaceuticals, Inc., a San Diego, California-based biopharmaceutical company focused on the development of new aerosol therapies for patients with respiratory diseases, closed a $30m tranched Series A financing. Investors includ... |